Business brief
Transatlantic Routes, Turnarounds, and Clean Tech M&A
Teva reaches a decade market high on drug pipeline progress, Israir breaks into transatlantic routes with FAA clearance, and Otovo buys Green Panel for $11M.
Business
Teva completed its turnaround — returning to investment grade as branded biopharmaceuticals replace legacy generic debt as the primary growth engine.
BackgroundTeva spent years restructuring under heavy debt burdens from generic price erosion and legacy opioid litigation settlements. CEO Richard Francis pivot towards proprietary branded biopharmaceuticals is now driving organic revenue growth and cash flow expansion.
- Moody's and Fitch restored Teva's debt to investment grade after sustained balance sheet deleveraging restored operating leverage
- The US FDA granted accelerated review for pediatric candidate Ecopipam, validating Teva's $700M acquisition of Emalex Biosciences
- Management raised full-year earnings guidance following strong second-quarter branded drug sales, boosting institutional buying across European and US listings
Business
Israir secured long-awaited US flight clearance — breaking El Al's transatlantic dominance just as foreign carriers return to Tel Aviv.
BackgroundDirect Tel Aviv to US flight corridors rank among the most lucrative air travel routes for Israeli carriers, historically dominated by flag carrier El Al. Suspensions by foreign airlines during regional security crises left significant unfulfilled passenger demand.
- FAA clearance provides the final regulatory approval required for Israir to operate direct scheduled routes into major East Coast US hubs
- Israir's entry expands direct seating capacity alongside El Al and Arkia ahead of high-volume autumn holiday travel periods
- Major US operators including United and Delta are preparing to restart Tel Aviv routes next month as flight safety conditions improve
Business
Otovo bought Green Panel for $11M — acquiring Israeli monitoring software to power commercial solar grid management across Europe.
BackgroundEuropean clean energy firms are buying behind-the-meter software tools that manage distributed rooftop solar and battery storage networks. Green Panel operates commercial solar monitoring across Israel and Hungary, projecting $12.8 million in revenue this year.
- Green Panel founder David Touti will take over Otovo's commercial energy management network spanning 15 European markets
- The transaction integrates Israeli software monitoring technology directly into Otovo's residential solar installation network across Europe
- The transaction highlights growing European interest in acquiring Israeli clean-tech software developers despite broader regional macroeconomic volatility
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
